HALOZYME THERAPEUTICS, INC.: capex
| Value | {"amount": 5543000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2025-01-01 – 2025-09-30 |
| Status | current |
| Entity | HALOZYME THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:36:33.282397+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/c9394034-2c84-4a23-bd34-f0864510e8e4
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001159036-25-000045Retrieved: 2026-08-19T11:36:33.282397+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001159036/capex/2025-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/c9394034-2c84-4a23-bd34-f0864510e8e4
History
- no predecessors — first report